Concentrations

12 Months Ended

Jun. 30, 2012

Concentrations [Abstract]

Concentrations

8.       Concentrations

At June 30, 2012, we had five distributors that individually accounted for 22%, 13%, 13%, 12% and 10% of accounts receivable. At June 30, 2011, we had one distributor that individually accounted for 14% of accounts receivable.

Revenues from one distributor totaled $6,746,000 or 35%, $7,824,000 or 33% and $9,890,000 or 43% of net revenues during the years ended June 30, 2012, 2011 and 2010, respectively.  For the year ended June 30, 2012, approximately 80% of the distributor's revenue came from one customer. Revenues from another distributor totaled $1,870,000 or 10% and $2,229,000 or 10% of net revenues for the years ended June 30, 2012 and 2011, respectively.

The following is a summary of product revenues as a percentage of total net revenues for the Company's principal product lines:

	2012			2011			2010
AXP		39	%		34	%		40	%
BioArchive		32	%		37	%		36	%
Res-Q/MXP		11	%		11	%		5	%
ThermoLine		4	%		6	%		7	%
CryoSeal		7	%		3	%		3	%

We had sales to customers as follows for the years ended June 30:

	2012		2011		2010
United States	$	10,783,000	$	13,745,000	$	13,827,000
Asia		4,010,000		3,697,000		4,303,000
Europe		1,806,000		3,453,000		3,117,000
South America		1,505,000		1,904,000		1,405,000
Other		919,000		601,000		436,000
	$	19,023,000	$	23,400,000	$	23,088,000

The Company has a contract manufacturer in Costa Rica that produces the AXP and MXP disposable bag sets.  The Company's net equipment is summarized below by geographic area:

	June 30, 2012		June 30, 2011
United States	$	1,269,000	$	904,000
Costa Rica		205,000		195,000
All other countries		178,000		211,000
Total equipment, net	$	1,652,000	$	1,310,000